Advertisement
Advertisement

DXCM

DXCM logo

DexCom, Inc.

74.87
USD
Sponsored
+1.13
+1.53%
Jun 01, 15:59 UTC -4
Closed
exchange

After-Market

74.60

-0.27
-0.36%

DXCM Earnings Reports

Positive Surprise Ratio

DXCM beat 32 of 42 last estimates.

76%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.32B
/
$0.62
Implied change from Q1 26 (Revenue/ EPS)
+10.38%
/
+10.71%
Implied change from Q2 25 (Revenue/ EPS)
+13.70%
/
+29.17%

DexCom, Inc. earnings per share and revenue

On Apr 30, 2026, DXCM reported earnings of 0.56 USD per share (EPS) for Q1 26, beating the estimate of 0.47 USD, resulting in a 17.03% surprise. Revenue reached 1.19 billion, compared to an expected 1.20 billion, with a -0.54% difference. The market reacted with a +3.02% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 23 analysts forecast an EPS of 0.62 USD, with revenue projected to reach 1.32 billion USD, implying an increase of 10.71% EPS, and increase of 10.38% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
FAQ
For Q1 2026, DexCom, Inc. reported EPS of $0.56, beating estimates by 17.03%, and revenue of $1.19B, -0.54% below expectations.
The stock price moved up 3.02%, changed from $59.55 before the earnings release to $61.35 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 23 analysts, DexCom, Inc. is expected to report EPS of $0.62 and revenue of $1.32B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement